デフォルト表紙
市場調査レポート
商品コード
1746981

日本の感染管理市場レポート:タイプ別、最終用途別、地域別、2025年~2033年

Japan Infection Control Market Report by Type (Equipment Disinfectors, Sterilization Equipment, Services, Consumables), End Use (Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 119 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.42円
日本の感染管理市場レポート:タイプ別、最終用途別、地域別、2025年~2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の感染管理市場規模は2024年に7億250万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに16億1,620万米ドルに達し、2025年から2033年にかけて9.1%の成長率(CAGR)を示すと予測しています。市場を牽引しているのは、診断ツールや感染管理ツールの急速な技術進歩、獣医・動物医療領域における需要の高まり、感染症予防の研究開発努力の高まり、ヘルスケア関連感染症(HAI)の回避に重点が置かれるようになっていることです。

本レポートで扱う主な質問

  • 日本の感染管理市場はこれまでどのように推移し、今後どのように推移するのか?
  • COVID-19が日本の感染管理市場に与えた影響は?
  • 日本の感染管理市場のタイプ別区分は?
  • 日本の感染管理市場の用途別区分は?
  • 日本の感染管理市場のバリューチェーンにおける様々なステージとは?
  • 日本の感染管理の主要な促進要因と課題は何か?
  • 日本の感染管理市場の構造と主要企業は?
  • 日本の感染管理市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の感染管理市場-イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の感染管理市場情勢

  • 過去および現在の市場動向(2019年~2024年)
  • 市場予測(2025年~2033年)

第6章 日本の感染管理市場- タイプ別内訳

  • 機器消毒装置
  • 滅菌装置
  • サービス
  • 消耗品

第7章 日本の感染管理市場- 最終用途別内訳

  • 病院
  • 医療機器企業
  • 臨床検査室
  • 製薬会社
  • その他

第8章 日本の感染管理市場-競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第9章 主要企業のプロファイル

第10章 日本の感染管理市場- 業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第11章 付録

目次
Product Code: SR112025A18523

Japan infection control market size reached USD 702.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,616.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.1% during 2025-2033. The market is being driven by swift technological progress in diagnostic and infection control tools, escalating demand within veterinary and animal healthcare domains, heightened research and development efforts in the prevention of infectious diseases, and an increasing emphasis on averting healthcare-related infections (HAIs).

Infection control encompasses a critical set of practices and measures put in place to prevent the dissemination and transfer of infections across diverse settings, including healthcare facilities, public areas, and workplaces. The primary objective is to safeguard individuals, patients, and healthcare personnel from acquiring and transmitting contagious diseases. Within healthcare environments, this entails the rigorous enforcement of procedures such as stringent hand hygiene, the utilization of personal protective equipment (PPE), proper sterilization and disinfection of medical apparatus, and the implementation of isolation precautions for patients with infectious conditions. These measures effectively curtail the risk of healthcare-related infections and ensure the safety of patients. In public spaces and workplaces, infection control measures may involve periodic cleaning and disinfection of surfaces, the promotion of respiratory hygiene, and the encouragement of vaccination to prevent the proliferation of communicable illnesses.

Japan Infection Control Market Trends:

In the context of the Japan market, the global market for infection control is primarily steered by the escalating prevalence of infectious diseases. This trend is closely linked to the expanding global population and urbanization, both of which play significant roles in market growth. Additionally, the increase in hospital-acquired infections is exerting a positive influence on the market's trajectory. Moreover, the emergence of drug-resistant pathogens and the surging demand for stringent infection control measures within healthcare facilities are acting as catalysts for market expansion. Furthermore, government regulations across various countries mandating infection control protocols are contributing to a favorable market outlook in Japan. Additionally, the growing emphasis on patient safety and heightened awareness regarding infection transmission in public spaces are propelling market growth. The aging population, which is more susceptible to infections, is also a driving force behind market expansion. Furthermore, rapid advancements in infection control technologies and products are providing a significant boost to the market. Other contributing factors include the expansion of healthcare infrastructure, increased healthcare expenditure, and a growing demand for infection control measures in dental and surgical procedures. These factors collectively will contribute to the positive outlook for the infection control market in Japan in the coming years.

Japan Infection Control Market Segmentation:

Type Insights:

  • Equipment Disinfectors
  • Sterilization Equipment
  • Services
  • Consumables

End Use Insights:

  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan infection control market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan infection control market?
  • What is the breakup of the Japan infection control market on the basis of type?
  • What is the breakup of the Japan infection control market on the basis of end use?
  • What are the various stages in the value chain of the Japan infection control market?
  • What are the key driving factors and challenges in the Japan infection control?
  • What is the structure of the Japan infection control market and who are the key players?
  • What is the degree of competition in the Japan infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Infection Control Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Infection Control Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Infection Control Market - Breakup by Type

  • 6.1 Equipment Disinfectors
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Sterilization Equipment
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Services
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Consumables
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)

7 Japan Infection Control Market - Breakup by End Use

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Medical Device Companies
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Clinical Laboratories
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Pharmaceutical Companies
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2019-2024)
    • 7.5.2 Market Forecast (2025-2033)

8 Japan Infection Control Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Services Offered
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Services Offered
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Services Offered
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Services Offered
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Services Offered
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan Infection Control Market - Industry Analysis

  • 10.1 Drivers, Restraints, and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix